EndoGene.Bio
Turning menstrual blood into better drugs for endometriosis.
Founded
2022
Founders
Maria Zaballos, CEO
Cristina Fernández Molina, Founding CSO
Madeleine Moscatelli, Founding CTO
endogene.bio is developing better treatments for endometriosis by using menstrual blood as a unique window into the disease. We combine patient data and laboratory models to discover new drug targets, understand why treatments work for some patients but not others, and help pharma develop better drugs.
Related
2by4
2by4
Your autonomous pre-construction team.
Starting with estimates.
8x
8x
Human orchestration for business outcomes.
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.